GENE ONLINE|News &
Opinion
Blog

LATEST
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
R&D
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
Dr. Joseph Kvedar: The Potential of Telemedicine in the Era of Digitalization
2020-05-07
Researchers Employ Novel CRISPR Tech to Accelerate COVID-19 Testing
2020-05-06
Human Monoclonal Antibody Breakthroughs Provide New Hope against COVID-19
2020-05-06
Llama Antibodies Show Promise as Probable Coronavirus Treatment
2020-05-05
AACR 2020: What Does Cancer Therapy Mean in the Time of COVID-19?
2020-05-04
New Antigen and Antibody-Based Kits Bolster Coronavirus Fight
2020-05-03
Virus-Associated Cancers and Advancements in Their Treatments
2020-05-03
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
1 183 184 185 186 187 218
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top